Uni Biotech Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -58.01%
- Profit Growth -97.09%
- Ebitda -16.48%
- Net Worth 0.08%
- Total Assets -38.29%
About Uni Biotech Pharmaceuticals
Uni Biotech Pharmaceuticals Private Limited (UBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 November 2004 and has a history of 20 years and two months. Its registered office is in Chennaai 600082, Tamil Nadu.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Cherukuri Rao and Hima Cherukuri serve as directors at the Company.
Company Details
-
LocationChennaai 600082, Tamil Nadu
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN2004PTC054768
-
Company No.
054768
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Nov 2004
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Uni Biotech Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cherukuri Rao
|
Director | 30-Nov-2004 | Current |
|
Hima Cherukuri
|
Director | 30-Nov-2004 | Current |
Financial Performance of Uni Biotech Pharmaceuticals.
Uni Biotech Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 58.01% decrease. The company also saw a substantial fall in profitability, with a 97.09% decrease in profit. The company's net worth moved up by a moderate rise of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uni Biotech Pharmaceuticals?
In 2022, Uni Biotech Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Etico Chemicals LlpCherukuri Rao is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uni Biotech Pharmaceuticals?
Unlock and access historical data on people associated with Uni Biotech Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uni Biotech Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni Biotech Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.